| Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates EE Walsh, RW Frenck Jr, AR Falsey, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 383 (25), 2439-2450, 2020 | 2615 | 2020 |
| COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... Nature 586 (7830), 594-599, 2020 | 1846 | 2020 |
| Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults MJ Mulligan, KE Lyke, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... Nature 586 (7830), 589-593, 2020 | 1707 | 2020 |
| Spike mutation D614G alters SARS-CoV-2 fitness JA Plante, Y Liu, J Liu, H Xia, BA Johnson, KG Lokugamage, X Zhang, ... Nature 592 (7852), 116-121, 2021 | 1641 | 2021 |
| Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ... Nature medicine 27 (4), 620-621, 2021 | 638 | 2021 |
| Neutralizing activity of BNT162b2-elicited serum Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ... New England Journal of Medicine 384 (15), 1466-1468, 2021 | 635 | 2021 |
| BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... Nature 595 (7868), 572-577, 2021 | 631 | 2021 |
| BNT162b vaccines protect rhesus macaques from SARS-CoV-2 AB Vogel, I Kanevsky, Y Che, KA Swanson, A Muik, M Vormehr, LM Kranz, ... Nature 592 (7853), 283-289, 2021 | 583 | 2021 |
| A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation AE Muruato, CR Fontes-Garfias, P Ren, MA Garcia-Blanco, ... Nature communications 11 (1), 4059, 2020 | 308 | 2020 |
| Vaccine mediated protection against Zika virus-induced congenital disease JM Richner, BW Jagger, C Shan, CR Fontes, KA Dowd, B Cao, ... Cell 170 (2), 273-283. e12, 2017 | 274 | 2017 |
| A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 X Xie, AE Muruato, X Zhang, KG Lokugamage, CR Fontes-Garfias, J Zou, ... Nature communications 11 (1), 5214, 2020 | 199 | 2020 |
| BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... MedRxiv, 2020.12. 09.20245175, 2020 | 183 | 2020 |
| RNA-based COVID-19 vaccine BNT162b2 selected for a pivotal efficacy study EE Walsh, R Frenck, AR Falsey, N Kitchin, J Absalon, A Gurtman, ... Medrxiv, 2020.08. 17.20176651, 2020 | 183 | 2020 |
| Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera PY Shi, X Xie, J Zou, C Fontes-Garfias, H Xia, K Swanson, M Cutler, ... Research square, 2021 | 176 | 2021 |
| Functional analysis of glycosylation of Zika virus envelope protein CR Fontes-Garfias, C Shan, H Luo, AE Muruato, DBA Medeiros, E Mays, ... Cell reports 21 (5), 1180-1190, 2017 | 157 | 2017 |
| 3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk HJ Park, P Ji, S Kim, Z Xia, B Rodriguez, L Li, J Su, K Chen, CP Masamha, ... Nature genetics 50 (6), 783-789, 2018 | 146 | 2018 |
| A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates AB Vogel, I Kanevsky, Y Che, KA Swanson, A Muik, M Vormehr, LM Kranz, ... BioRxiv, 2020.09. 08.280818, 2020 | 134 | 2020 |
| BNT162b2-elicited neutralization against new SARS-CoV-2 spike variants Y Liu, J Liu, H Xia, X Zhang, J Zou, CR Fontes-Garfias, SC Weaver, ... New England Journal of Medicine 385 (5), 472-474, 2021 | 104 | 2021 |
| Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... MedRxiv, 2020.07. 17.20140533, 2020 | 83 | 2020 |
| A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission C Shan, H Xia, SL Haller, SR Azar, Y Liu, J Liu, AE Muruato, R Chen, ... Proceedings of the National Academy of Sciences 117 (33), 20190-20197, 2020 | 62 | 2020 |
